A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial). [electronic resource]
Producer: 20110623Description: 747-54 p. digitalISSN:- 1468-2060
- Adolescent
- Antibodies, Bacterial -- biosynthesis
- Antirheumatic Agents -- adverse effects
- Arthritis, Juvenile -- blood
- Biomarkers -- blood
- Blood Sedimentation
- C-Reactive Protein -- metabolism
- Child
- Child, Preschool
- Double-Blind Method
- Female
- Gene Expression Profiling -- methods
- Humans
- Interleukin 1 Receptor Antagonist Protein -- adverse effects
- Male
- Pneumococcal Vaccines -- immunology
- Polysaccharides, Bacterial -- immunology
- Severity of Illness Index
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.